A B S T R A C T The presence and distribution of C3b receptors in normal human kidneys and in biopsies from 75 patients with renal disease were investigated by immunohistochemical techniques using monospecific rabbit antibody to the 205,000-mol wt glycoprotein that is the C3b receptor of human peripheral blood cells. Anti-C3b receptor bound exclusively to podocytes in normal renal cortex, and was homogeneously distributed on the plasma membrane of these cells. Biosynthesis of the receptor by the podocyte was suggested by the presence of antigenic activity in the Golgi apparatus. Although occupancy of receptor sites following the interaction of kidney sections with aggregated IgG preincubated with normal serum inhibited binding to glomeruli of C3b coated cells, the C3b receptor remained accessible to anti-C3b receptor antibody. No staining of podocytes was found in extracapillary proliferating cells in rapidly progressive glomerulonephritis (GN). Segmental loss of staining was found in focal hyalinosis, nodular diabetic glomerulosclerosis, and amyloidosis while no detectable C3b receptor antigen was found in severe proliferative nephritis of systemic lupus erythematosus (SLE). Normal staining of podocytes was found in other nephropathies with endocapillary proliferation such as acute GN and mesangial GN and in renal diseases associated with immune deposits containing C3 such as mesangial proliferative and membranous SLE nephritis, idiopathic INTRODUCTION Sheep erythrocytes and bacteria bearing C3b and C3bi, cleavage fragments of the third component of complement, adhered to glomeruli in frozen sections of human kidney (1) (2) (3) (4) . These particles were also found to adhere to the main body and trabecules of visceral epithelial cells (podocytes) from freshly prepared or cultured glomeruli (5, 6) , indicating that at least the podocyte expressed receptor activity for fragments of C3. Decreased glomerular binding of particles bearing C3b and/or C3bi suggested depressed receptor activities in various renal diseases. Decreased receptor activities have been found to be independent of the site of C3 deposition (6) , or correlated with mesangial (7) or parietal (8) (9) (10) (11) (18) . Ultrathin sections were cut using a Reichert OmU2 ultramicrotome (Reichert-Jung, Paris, France) and examined with a Zeiss EM9 or EM10 electron microscope (Carl Zeiss Inc., West Germany). Controls for endogenous peroxidase activity were sections treated as above with the exception of incubation with anti-C3b receptor antibody.
Binding of C3b-bearing cells to glomeruli. Sheep erythrocytes sensitized with rabbit antibody and bearing human C3b (EAC4b3b) were prepared as described (19) . Two Immunohistochemical Study of Human Glomerular C3b Receptor (Fig. 1) Using an indirect immunoperoxidase technique and electron microscopy, homogeneous granular staining was present on the surface of podocytes including the main body, trabecules, and pedicels (Fig. 2) . Although less intense, C3b receptors were stained in the basement membrane-embedded part of the pedicels. The reaction product was seen within the Golgi apparatus of some podocytes but in no other intracellular location (Fig. 3) Table I were examined by indirect immunofluorescence for the presence of the C3b receptor. Normal pattern of staining of the C3b receptor on podocytes was seen in all biopsies from patients with minimal changes disease (lipoid nephrosis, LN). Normal pattern was also seen in patients with diseases in which parietal immune deposits occur such as idiopathic membranous nephropathy (MGN) (Fig. 5) , membranoproliferative glomerulonephritis (MPGN) types I and II, acute glomerulonephritis (AGN) and with diseases in which mesangial immune deposition is present such as mesangial glomerulonephritis (MSGN) with IgA and/or C3 deposition and Henoch Sch6nlein's purpura. Thus among these diseases, no alteration in the pattern of C3b receptor staining was observed, irrespective of the presence or site of immune deposits including C3 deposition, or the presence of endocapillary proliferation (MPGN type I and type II, AGN, MSGN, Henoch Schonlein's purpura). The pattern of staining with anti-C3b receptor antibody was also normal in toxemia of pregnancy, transplanted kidneys with or without FIGURE 7 RPGN with anti-GBM antibodies and extracapillary proliferation. Anti-C3b receptor was revealed by antirabbit IgG antibody that cross-reacted with human IgG. All extracapillary cells (e) in the area of crescentic proliferation, where no GBM was stained, are negative (X300). (Fig. 6) . In a biopsy from a patient with Goodpasture's syndrome and using as a revealing antiserum for indirect immunofluorescence a sheep anti-rabbit IgG that crossreacted with human IgG, staining of anti-GBM antibodies was observed. The area of crescentic proliferation outside the GBM was negative (Fig. 7) . Thus the cells involved in extracapillary proliferation do not express the C3b receptor.
In focal hyalinosis, which is not characterized by extracapillary proliferation, altered patterns of C3b receptor staining were also observed; in the segmental lesions no staining of podocytes was seen, while in the residual areas of the glomeruli these cells expressed C3b receptor antigen (Fig. 8) . Upon light microscopic examination, segmental lesions in focal hyalinosis include alteration and detachment of podocytes from the capillary wall, followed by their progressive disappearance (20, 21) (Fig. 9a) . Examination sections of a biopsy from a patient with a form of the revealed that the podocytes had entirely lost their abildisease that involved almost all glomeruli, stained with ity to express C3b receptor antigen (Figs. 9b and c In two diseases where there is no renal deposition of C3, amyloidosis and the nodular form of diabetic glomerulosclerosis, areas adjacent to the amyloid deposits or the glomerulosclerotic nodules did not stain with anti-C3b receptor antibody. In contrast, podocytes in biopsies from patients with moderate diffuse diabetic glomerulosclerosis expressed C3b receptor antigen in a normal distribution.
DISCUSSION
Antibody to the C3b receptor of human erythrocytes (12, 13) , which also recognizes the receptor on human polymorphonuclear leucocytes, B lymphocytes, and monocytes, bound to the podocytes in glomeruli from normal human renal cortex (Figs. 1, 2, and 3 ). C3b receptor activity had been recognized on these cells in previous studies (1, 5, 6) by the adherence of C3b-coated particles. Immunohistochemical techniques utilizing anti-C3b receptor antibody demonstrated the C3b receptor antigen to be present on podocytes and on no other cell type in the renal cortex (Fig. 1) . Ultrastructural examination showed the antigen to be homogeneously distributed on the plasma membrane of the main body, trabecules, and pedicels of the podocyte (Fig. 2) . The receptor was present even in areas where the pedicels are embedded in the lamina rara externa; occasional decrease in staining in these areas might represent either impaired penetration of the antibody or diminished number of receptors (Fig. 2) . Synthesis of the receptor molecule by podocytes was suggested by the presence of the antigen within the Golgi apparatus (Fig. 3) . Thus the C3b receptor activity that had been recognized in human glomeruli represents a membrane protein of the podocyte that is antigenically related to the gp 205 receptor of peripheral blood cells.
Crescentic areas of extracapillary proliferation whether segmental or diffuse, did not stain with antiC3b receptor antibody suggesting that these cells are not podocytes (Figs. 6 and 7 ). There is some question about the origin of the proliferating cells; they are thought to be parietal epithelial cells (23) , but have also been considered to be derived from podocytes (24) , or from bone marrow-derived monocytic cells (25) . The inability to detect the C3b receptor, which is a normal constituent of the peripheral blood monocyte (4, 13, 26), does not allow to differentiate whether the cells in crescentic areas are of monocytic or parietal epithelial cells origin, since mononuclear cells infiltrating the interstitium in biopsies of patients with acute transplant rejectiQn or interstitial nephritis did not stain for C3b receptor. The absence of staining of infiltrating cells, although peripheral blood monocytes stain in suspension, may be due to loss of receptor or, more likely, to the low density of receptors on monocytes as compared with podocytes, as suggested by immunoelectron microscopy and by comparing the staining of podocytes in normal glomeruli ( Fig. 1) with that of peripheral blood cells in suspension (27, 28) .
Altered patterns of staining for this specific membrane marker of the podocyte was found in the unrelated diseases: focal hyalinosis (Figs. 8 and 9 ), diffuse proliferative SLE nephritis (Fig. 11) , the nodular form of diabetic glomerulosclerosis, and amyloidosis. In both nodular diabetic glomerulosclerosis and amyloidosis, decreased staining with anti-C3b receptor could in part be related to the loss of podocytes in the acellular areas. However, podocytes are present in the perinodular capillaries of the diabetic nodular lesions and have been noted to appear enlarged and detaching from the capillary wall (29) . In focal hyalinosis, podocytes in the areas of focal lesions and throughout the glomerulus in diffuse hyalinosis where there is no staining for C3b receptor, are also enlarged, vacuolated and in the process of detaching from the GBM (Fig. 9a) (20) . Thus the loss of detectable C3b receptor antigen could not have been secondary only to the loss of podocytes but may reflect a metabolic abnormality of the podocyte, which has impaired biosynthesis of this membrane protein. However in another example of altered podocyte function, LN in which there is dedifferentiation of the foot processes accompanied by histochemical alterations of the podocyte's cell coat (30) , a normal distribution of the C3b receptor antigen was found.
As the C3b receptor has been shown on polymorphonuclear leukocytes to be capable of mediating adsorptive endocytosis of ligand (27) leading to clearance of the receptor from the plasma membrane, it was important to consider, as has been suggested in previous studies of the C3b receptor in immune nephropathies (7-1 1), whether undectable receptor content of podocyte in SLE nephritis type IV could be related to a similar interaction. However, decreased receptor antigen could not be correlated simply to the presence of immune deposits containing C3 since reaction of glomeruli with NHS that had been preincubated with aggregated IgG did not alter the staining of podocytes with anti-C3b receptor antibody (Fig. 4) , and since normal immunofluorescence patterns with anti-C3b receptor antibody were observed in glomeruli from patients with SLE nephritis type II (Fig. 10 ) and type V, idiopathic MGN (Fig. 5) , MPGN type I and II, AGN, MGSN with IgA or C3 deposition, and HenochSch6nlein's purpura in which both C3 and/or immunoglobulin deposits are found in parietal (subendothelial, intramembranous, or subepithelial) or mesangial location (Table I) . Moreover, C3 deposits were not a constant feature of focal hyalinosis (Table I) . Among the different types of SLE nephritis there was an association between the loss of C3b receptor antigen (Figs. 6, 10, and 11) and the severity of endocapillary proliferation which has been suggested to be predictive of a poor renal prognosis (31) . In the nonproliferative types II and V, C3b receptor antigen staining was normal; in biopsies with type IV SLE nephritis, there was no detectable C3b receptor antigen although podocytes could be seen in glomeruli showing similar lesions; in biopsies with type III, the pattern of staining with anti-C3b receptor was inversely related to the extent of proliferative changes. This apparent correlation between loss of receptor antigen and endocapillary proliferation however was not found in other endocapillary proliferative diseases such as AGN, MPGN, or MSGN. Therefore the proliferative nephritis of lupus has specific abnormality of the podo-cyte, loss of C3b receptor antigen, which distinguishes it both from nonproliferative lupus nephritis and other immunologically mediated proliferative glomerulonephritis.
In the present study, loss of C3b receptor antigen among nephropathies thought to be of immune origin, was restricted to focal hyalinosis and severe proliferative nephritis of SLE. This finding is in apparent contrast to earlier reports of receptor function that found decreased binding of C3b-coated particles to glomeruli in most immune nephropathies. However, adherence reactions could not differentiate between receptor loss and receptor occupancy by C3b in immune deposits; since receptor sites occupied by their natural ligand remained accessible to anti-receptor antibody (Fig. 4) , the absence of immunofluorescence with anti-C3b receptor indicates the deletion of this membrane protein from the podocyte. The latter abnormality suggests that in focal hyalinosis and severe proliferative nephritis of SLE, there is an alteration in the biosynthesis or turnover of the receptor by the podocyte that is not a feature of other renal diseases. 
